Radiometer is a leading provider of technologically advanced acute care solutions that simplify and automate all phases of acute care testing.
With more than 3,200 employees worldwide and direct representation in 32 countries, we help healthcare professionals get fast and accurate information on the most critical parameters in acute care testing, including oxygen, lactate and troponin.
This is the foundation for making immediate and well-informed decisions on the treatment of critically ill patients in clinical settings such as emergency care, intensive care, anesthesiology, cardiac surgery, neonatal care and wound care.
Radiometer develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and the related IT management systems.
Radiometer develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and related IT management systems under the ABL, AQT, TCM, RADIANCE, AQURE, PICO, CLINITUBES and QUALICHECK brand names
Founded in 1935 and headquartered in Copenhagen, Denmark, Radiometer was a pioneer in blood gas testing, introducing the world’s first commercially available blood gas analyzer in 1954.
Today, Radiometer’s products and solutions are used in hospitals, clinics and laboratories in over 130 countries, to provide information on the most critical parameters in acute care testing.
In fact, six samples are performed every second on a Radiometer analyzer somewhere in the world. That’s 360 samples a minute, 21,600 samples an hour, 518,400 samples a day. That’s 189,216,000 samples every year tested on a Radiometer analyzer somewhere in the world.
- Direct representation in 32 countries
- More than 100 distributors cover the rest of the world
- Production/R&D companies in Denmark, USA, Switzerland, Finland, Poland and India
Radiometer is part of Danaher Corporation’s (NYSE:DHR) life sciences and diagnostics platform, offering a broad range of analyzers, consumables, software and services used to diagnose diseases and make treatment decisions in pathology labs, hospitals and other critical care settings.
Other life sciences and diagnostics companies owned by Danaher Corporation are HemoCue (part of the Radiometer Group), Beckman Coulter, Leica Microsystems, Leica Biosystems, Molecular Devices and AB Sciex.
The Benefit of Using a D-dimer Assay with a High Clinical Specificity
Webinar presented by Karin Strandberg, MD, PhD, Assoc. Prof, Consultant, Labmedicine, Skåne, Sweden
This webinar is scheduled as two sessions to accomodate for participants in different time zones.
November 29, 2016 - 12:00 PM CET (Paris, Berlin, Copenhagen)
November 29, 2016 - 4:00 PM CET (Paris, Berlin, Copenhagen)
About this webinar
D-dimer can be used to exclude venous thromboembolism (VTE) in
outpatients. Together with a low pretest probability for VTE, a negative
D-dimer can safely rule out VTE in 30-50 % of patients with suspected
To date, there is no standardisation of D-dimer tests, which causes variation in results among methods.
This webinar will discuss pitfalls and limitations of the D-dimer
analyte with special focus on the performance differences among methods.
The use of D-dimer requires a method with particular performance characteristics, most importantly:
- A high sensitivity and negative predictive value (NPV) to ensure
that patients with VTE are not falsely characterized as ”not sick”
- Acceptable diagnostic specificity to minimize the number of radiological imagings on patients without VTE
- Good reproducibility around the cut-off (decision limit) to
ensure reproducibility of whether a result is ”positive” or ”negative”.
A verification of the performance of the assay in the local clinical
population is also recommended, but it is a difficult and time-consuming
task. Publications on comparisons between methods are therefore
sometimes used to support the choice of method and the cut-off.
Besides a sensitivity and negative predictive value (NPV) as close to
100 % as possible, a high specificity is of importance to limit the
number of unnecessary radiological imagings for the benefit of the
patient and to improve logistics and lower the costs of the health care
Who should attend?
- ED doctors and nurses
- Respiratory doctors
- Lab managers
- POC managers
- ICU doctors
- Operation theater doctors and nurses
One PACE® credit will be provided for each session
- Each session is approved for 1 Florida CE credit
Florida Board of Clinical Laboratory Personnel approved number:
- A Certificate of Attendance will be available for all
sessions for international participants to submit to their appropriate
Note: You can now join Webex Event Center from iPhones,
iPads, and Android devices. Visit the Apple Store or Google Play to
install the latest free app on your device.
is a Radiometer-sponsored knowledge website that combines scientific literature
with daily practice on topics relevant to acute care testing
On http://acutecaretesting.org/acutecaretesting.org you will find
articles on clinical issues written by international experts and healthcare
professionals such as physicians, clinical chemists, point-of-care
coordinators, nurses, laboratory professionals and respiratory therapists.
a high level of quality and relevance on topics surrounding acute care testing.
Knowledge creating value
covered on acutecaretesting.org:
- Blood gases, electrolytes, glucose, lactate and creatinine
- Cardiac markers, hemostasis/coagulation and sepsis
- Point-of-care testing, process optimization and information
- Quality assurance, prevention of preanalytical errors and the
http://acutecaretesting.orgacutecaretesting.org is often referenced
in publications and conferences as a source of information and has more than
27,000 registered users and over 21,000 subscribers worldwide.
care testing handbook
critical parameters in acute care testing – available in one handbook
acute care testing handbook is available as an e-book offering a practical
guide to critical parameters in acute care testing such as pO2, lactate and troponin.
parameters in acute care testing